Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure used to treat severe aortic stenosis, a condition characterised by the narrowing of the aortic valve in the heart.
During a TAVR procedure, a catheter with a collapsible artificial valve is inserted through a small incision, usually in the groin or chest, and guided to the site of the narrowed aortic valve. The replacement valve is then expanded, pushing the old valve leaflets aside and allowing the new valve to take over the function of regulating blood flow.
TAVR is typically recommended for patients with severe aortic stenosis who are considered at high risk for open-heart surgery due to factors such as advanced age, frailty, or the presence of other medical conditions. However, TAVR is also increasingly being used in intermediate-risk patients and has shown favourable outcomes in these populations as well.
Mr. Mohammed Yousuf from Hyderabad successfully underwent TAVR for Severe Aortic Stenosis at Yashoda Hospitals, Hyderabad, under the supervision of Dr. Bharat Vijay Purohit, Senior Consultant Interventional Cardiologist and Director of Cath Lab.